Incidentie prostaat

Selections made

Dataset	change	Incidence \| Prostate
Region	change	Nation wide
outcome	change	Numbers
Period	change	1990 / 1995 / 2000 / 2005 / 2010 / 2014 / 2015 / 2016*
Gender	change	Male
Age groups	change	Total
Behavior	change	Invasive

Table

Incidence | Prostate; Nation wide; Male; Invasive

Behavior

Invasive

Gender

Male

Region

Nation wide

Tumour

Period

outcome

Total

Prostate

1990

4299

Prostate

1995

6629

Prostate

2000

7078

Prostate

2005

9004

Prostate

2010

10742

Prostate

2014

10015

Prostate

2015

10469

Prostate

2016*

11064

Graph

line|bar

Incidence | Prostate; Nation wide; Male; Invasive

Numbers

Year of diagnosis

Total

About

Incidence

The incidence of cancer is defined as the number of new cancers of a specific site occurring in a specified population during a year. This is usually expressed as the number of cancers per 100,000 persons a year: the crude rate. To adjust for the age distribution of the population, the crude incidence is often adjusted for the European or World standard popoluation, resulting in the European Standardized Rate (ESR) or World Standardized Rate (WSR).

Updated 02-02-2017, the rates for 2016 are based on estimations.

Numbers

Gender

Age groups

Behavior


	Select tumours incidence survival prevalence mortality risk Main group select all deselect all All sites Head and neck Digestive tract Respiratory tract Melanoma & other malignant neoplasms of the skin Bone and articular cartilage Breast Female genital organs Male genital organs Urinary tract Hematology Endocrine glands Eye Brain and other parts of central nervous system Other sites select all deselect all Lip Oral cavity Pharynx Salivary glands Paranasal sinuses Larynx Unknown primary of the head and neck Melanoma of the upper aerodigestive tract Oesophagus Oesophagogastric junction Stomach Small intestine Large intestine Anus/anal canal Liver Gallbladder and extrahepatic bile ducts Pancreas Gastrointestinal tract NOS GI carcinoid tumours Gastrointestinal melanoma GIST Trachea Lung/bronchus Mesothelioma Thymus Skin, basal cell carc. Skin, squamous cell carc. Skin adnex carcinoma Merkel cell carcinoma Skin, melanoma all Dermatofibrosarcoma Kaposi sarcoma Soft tissue sarcoma Bone and joint of limbs Neuroblastoma (extracerebral) Paraganglioma Invasive breast cancer DCIS Phyllodes tumor Sarcoma in the breast Vulva Vagina Cervix Uterus Sarcoma of the uterus Ovary and fallopian tube Other and unspecified tumors of the female genital organs Placenta Sarcomas of the vagina and unspecified female genital organs Penis Prostate Testis Extragonadal / extra cerebral germ cell tumors Other male genital organs Kidney Renal pelvis and ureter Bladder Other urinary system Sarcoma of the urinary system Hodgkin lymphoma B-CLL / small cell B-cell lymphoma Indolent non-Hodgkin lymphoma Agressive NHL Plasma cell tumors Mature T- and NK-cell tumors (excl. skin lymphomas) Cutaneous lymphomas Lymphoblastic leukemia / lymphoma Acute Myeloid Leukaemia Leukaemia, other Myeloproliferative disorders MDS and Myelodysplastic/Myeloproliferative Disorders Histiocytic and dendritic cell neoplasm Thyroid gland Adrenal gland and other endocrine organs Carcinoma of conjunctiva Cornea Lacrimal gland Retinoblastoma Sarcoma of the orbit Eye tumor other/NOS Melanoma of the eye CNS sarcomas Brain Spinal cord Meninges Cranial nerves Pituitary gland/sella turcica Epiphysis Intracerebral germ cell tumors Other sites Primary site unknown select all deselect all Tongue, other Gum Floor of mouth Palate Oral cavity NOS Oropharynx Nasopharynx Hypofarynx Mouth and pharynx NOS Parotid gland Major salivary glands, other Nasal cavity and middle ear middle ear carcinoma Carcinoma of the sinus maxilaris Carcinoma of the sinus ethmoidalis Sinus carcinoma, other Supraglottic carcinoma Glottic carcinoma Subglottic carcinoma Other/unspecified Cervical esophageal carcinoma Esophageal carcinoma (excl cervical) Duodenal carcinoma Small intestine carcinoma Colon carcinoma Appendix Rectum carcinoma Rectosigmoid carcinoma HCC Intrahepatic cholangiocarcinoma Neuroendocrine liver tumor Hepatoblastoma Carcinoma of the gallbladder Cystic duct Common bile duct Hepatic duct Common bile duct Ampulla of Vater Carcinoom Neuro endocrien Appendix carcinoid Carcinoid of the stomach Carcinoid of thesmall intestine Ampulla of Vater carcinoid Carcinoid of the colon Gastrointestinal carcinoid, other Carcinoid of unknown primary Esophagal melanoma Anorectal melanoma Melanoma other/NOS Gastric GIST Gastric Leimyosarcoma Intestinal GIST, excl gastric Leimyosarcoma of the digestive system Angiosarcoma of the liver Other intestinal sarcomas NSCLC SCLC Lung carcinoid Other/unspecified Pleuropulmonal blastoma Soft tissue sarcoma head and neck Soft tissue sarcoma of the extremities Thoracal soft tissue sarcoma Sarcoma of the lung and trachea Abdominal soft tissue sarcoma Soft tissue other and NOS Chondrosarcoma Osteosarcoma Ewing sarcoma Giant cell tumor Odontogenic sarcoma Chordoma Other bone tumors PCC of the vulva BCC of the vulva Epithelial ovarian carcinoma Extra-ovarian cancer Non-epithelial ovarian carcinoma Nonepithelial tuba carcinoma Tuba carcinoma Seminoma Non-seminoma Stromal tumor of the testis Carcinoma of the testis Kidney carcinoma Nefroblastoma Pyelum carcinoma Ureter carinoma Superficial bladder carcinoma Muscle-invasive bladder cancer Classical Hodgkin lymphoma Nodular lymphocyte predominant hodgkin lymphoma B-CLL Small cell B-cell lymphoma Follicular lyphoma Lymphoplasmacytic lymphoma / Waldenström's macroglobulinemia Other indolent NHL Hairy cell" leukemia B-PLL Mantle-cell lymphoma Burkitt lymphoma/leukemia Diffuse large B-cell lymphoma (DLBCL) and variants Lymphomas other/NOS Plasma cell myeloma (multiple myeloma) Plasma cell leukemia Solitary plasmacytoma Extramedullar plasmacytoma T/NK-cell leukemia T/NK-cel lymphoma Cutaneous B-cell lymphomas Cutaneous T-cell lymphomas B-ALL, NOS B-ALL with specific cytogenetic abnormalities B-LBL T-ALL T-LBL AML with specific cytogenetic abnormalities AML with myelodysplasia-related changes AML after previous cytotoxic chemotherapy and / or radiotherapy AML, other/NOS Myeloid sarcoma Myeloid leukemia in Down's syndrome Blastic plasmacytiod dendritic cell neoplasm Acute undifferentiated leukemia Biphenotypic leukemia Leukemia NOS Chronic Myeloid Leukaemia Mast cell tumors Myelofibrosis Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1 Myeloproliferative Neoplasm, other Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Disorders Histiocytic sarcoma Langerhans cell tumors Dendritic cell sarcoma Papillary and follicular carcinoma of the thyroid gland Medular carcinoma of the thyroid gland Anaplastic carcinoma of the thyroid gland SCC of thyroid gland Thyroid gland other/nos Adrenal cortex Parathyroid carcinoma Other endocrine organs reset process Name of this selection:


	Select indicator Main group Mammacarcinoom Rectum n.t.b. n.t.b. n.t.b. n.t.b. n.t.b. n.t.b. n.t.b. n.t.b. n.t.b. n.t.b. n.t.b. n.t.b. n.t.b. n.t.b. n.t.b. n.t.b. Aantal resecties (en) 30 days mortality after colon surgery x x x reset process Name of this selection: